Company
TelePeptide
TelePeptide publishes unspecified GLP-1, compounded semaglutide, oral semaglutide and compounded tirzepatide, from $149 to $249 a month.
- 6 programs
- 4 molecules
- 12 readings
Read from telepeptide.org on September 3, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to TelePeptide
We earn nothing from this link. TelePeptide has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Microdose GLP-1 Combos, monthly (no commitment)
first month, including the required fees on record · Semaglutide Injectable, monthly (no commitment)
first month, including the required fees on record · Semaglutide + Naltrexone Anti-Nausea, monthly (no commitment)
first month, including the required fees on record · Semaglutide Dissolvable Tablet, monthly (no commitment)
first month, including the required fees on record · Tirzepatide Injectable, monthly (no commitment)
first month, including the required fees on record · Tirzepatide Dissolvable Tablet, monthly (no commitment)
Terms
| Consultation fee | Charged, and the amount is not published. A professional medical consultation fee, paid to the independent licensed clinician or clinician group, applies to each consultation and is included in the program price you pay - it is not billed as a separate charge. The specific consultation fee applicable to your care is disclosed at checkout. |
|---|---|
| States | All states except Alaska and Mississippi (plus the District of Columbia) |
Not yet checked: pharmacy and membership.
Terms can differ between this company’s programs; each entry carries its own.
Programs
| Entry | Provider | Form | Per month at its shortest term | Link |
|---|---|---|---|---|
| TR-0501 | TelePeptide | $149 Microdose GLP-1 Combos, monthly (no commitment) | Record | |
| TR-0496 | TelePeptide | $199 Semaglutide Injectable, monthly (no commitment) | Record | |
| TR-0498 | TelePeptide | Sublingual | $209 Semaglutide + Naltrexone Anti-Nausea, monthly (no commitment) | Record |
| TR-0497 | TelePeptide | Sublingual | $229 Semaglutide Dissolvable Tablet, monthly (no commitment) | Record |
| TR-0499 | TelePeptide | $249 Tirzepatide Injectable, monthly (no commitment) | Record | |
| TR-0500 | TelePeptide | Sublingual | $249 Tirzepatide Dissolvable Tablet, monthly (no commitment) | Record |
Notes
Recorded against this company rather than one program.
September 3, 2026
- 1. TelePeptide names the two states it does not serve rather than listing the rest: “TelePeptide currently provides telehealth services in 48 US states and the District of Columbia; we do not serve residents of Alaska or Mississippi at this time.” The 48 are recorded from that sentence. Its consultation fee is disclosed but never priced on the site — the terms say the fee “is included in the program price you pay - it is not billed as a separate charge”, and that “the specific consultation fee applicable to your care is disclosed at checkout”.
September 2, 2026
- 2. The most transparent price chart found in this batch: a full 4-tier (monthly/3-month/6-month/annual) price table published for six GLP-1 SKUs (semaglutide injectable, semaglutide dissolvable tablet, semaglutide+naltrexone combo, tirzepatide injectable, tirzepatide dissolvable tablet, and a 9-formula 'microdose' combo line recorded as unspecified GLP-1). Although the site's own footer describes state coverage tersely as '48 states + DC... AK and MS not served' (an exclusion phrasing), the dedicated /state-coverage page separately prints the full enumerated 'Currently served' list of all 48 state names plus DC, so the served list was taken from that page rather than left not-found. Neither injectable product page states vial vs. pen.
Before you act
Cite this
Treatment Registry. (2026). TelePeptide: recorded programs and prices. Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/telepeptide